Blood Analyzers in Ohio

Tosoh Bioscience, a division of Tosoh Corporation (established 1935, Tokyo Stock Exchange listed), is a global provider of clinical diagnostic analyzers and separation & purification chromatography solutions. The Clinical Diagnostics division serves clinical laboratories, hospitals, and healthcare systems with immunoassay testing platforms and assays spanning oncology, diabetes, fertility, and endocrinology applications. The Separation & Purification division supplies liquid chromatography systems and consumables for biopharma, biotech, chemical, and research industries, with specializations in antibody analysis, biomolecule separation, oligonucleotide purification, and polymer characterization. Key product lines include the AIA-2000 high-throughput immunoassay analyzer, AIA-900 with automated sample handling, SkillPak pre-packed chromatography columns, and LenS3 MALS detector systems. The company operates manufacturing and service capabilities across multiple regions (US, Europe, Japan, China, India, Asia-Pacific) and supports bioprocess development, analytical testing, and research applications. Tosoh maintains a global workforce of over 14,000 across 100+ companies and serves principal markets in chemicals, bioscience, automotive, consumer electronics, and environmental sectors.

Aniara Diagnostica is a specialist North American distributor of hemostasis, coagulation, and genotoxicity reagents serving hospital coagulation laboratories, academic research institutions, and industrial quality control labs across the United States, Canada, and Nordic regions. The company is the exclusive North American distributor for HYPHEN BioMed's BIOPHEN™ and HEMOCLOT™ product families, including anti-Xa and anti-IIa chromogenic assays, DOAC monitoring reagents for dabigatran, rivaroxaban, apixaban, and edoxaban, and thrombophilia testing kits. Aniara also distributes platelet aggregation reagents, the ZYMUTEST™ HIA IgG (the only 510(k)-cleared IgG-specific HIT antibody ELISA in the US), DOAC-Remove activated charcoal tablets and DP-Filter from 5-Diagnostics for plasma specimen preparation, 5-Diagnostics pharmacopoeial heparin potency kits, Medicago buffer reagents and lectins, and Xenometrix Ames mutagenicity and genotoxicity test systems. The company specializes in coagulation science and has been family-owned since 2004, based in West Chester, Ohio. Products are designed for use in clinical diagnostics, research, and pharmaceutical quality control.

DiaPharma Group, Inc. manufactures specialty research and clinical assay kits, reagents, and hemostasis analyzers for bleeding/clotting disorders, thrombosis, liver disease, drug-induced organ injury, and anti-cancer drug development. Founded in 1997, the company employs scientists with expertise in hemostasis, coagulation testing, platelet function analysis, fibrosis biomarkers, and NETosis research. DiaPharma offers chromogenic substrates, ADAMTS13 assays, Factor X testing, and mechanistic biomarkers for MASH, alcoholic liver disease (ALD), and drug-induced liver injury (DILI). The company provides personalized scientific support and customer service to clinical laboratories, research institutions, and pharmaceutical development teams.

HealthChek Network, LLC is a family-owned wellness screening provider founded in 1985, operating affordable health and laboratory testing services across Indiana, Illinois, Wisconsin, and Michigan. The company specializes in accessible wellness screenings, drug testing, seasonal vaccinations, and clinical laboratory testing with a commitment to eliminating patient anxiety around blood draws. HealthChek operates physical screening locations in Schererville, IN and Streator, IL, and offers on-site screening events at client locations. Their services emphasize early detection and prevention, with reasonable pricing, professional technicians, and customer privacy as core values. The company accepts multiple payment options and provides fast, reliable results sent directly to patients and healthcare providers.

Sejoy is a high-tech medical device manufacturer founded in 2002, specializing in home-care electronic medical products and point-of-care diagnostic systems. The company designs, develops, manufactures, and markets a comprehensive portfolio of monitoring and testing devices including blood glucose monitoring systems, lipid panel analyzers, hemoglobin monitoring systems, uric acid monitoring systems, urine analysis systems, infectious disease testing platforms, drug-of-abuse testing solutions, and fertility testing systems. All products are manufactured under ISO 13485 quality management standards and hold regulatory certifications including FDA approval, CE marking (European), RoHS, REACH, MDSAP, and FCC compliance. Sejoy operates three major technology research and development platforms: electromechanical, optoelectronic, and biochemical. The company maintains a strong R&D team with over 80% of staff holding bachelor's or master's degrees. Manufacturing capabilities include full quality control protocols (IQC, IPQC, FQC, OQC) with 100% pre-shipment inspection. The company offers OEM/ODM services for customization of color, packaging, user manuals, and functional design modifications. Warranty coverage includes one year of complimentary service with lifetime after-sales support. Sejoy serves global markets with a focus on cost-effective, clinically validated diagnostic instruments suitable for clinical laboratories, point-of-care facilities, and home health monitoring applications.

Fertility Solutions is a specialized manufacturer and CLIA high-complexity laboratory provider focused exclusively on semen analysis solutions. Based in Warrensville Heights, Ohio, and serving the Cleveland region for over 30 years, the company manufactures FDA-cleared semen analysis quality controls and laboratory reagents. Their product portfolio includes quality control materials for sperm count, morphology, motility, viability, and post-vasectomy assessment, as well as specialized staining kits and diagnostic instruments like the Spermocytometer. Beyond manufacturing, Fertility Solutions operates a certified laboratory providing semen analysis services for patients and contract research, and offers comprehensive competency training programs, post-training examinations, and validation sets to support clinical laboratory compliance with CLIA requirements. The company also serves veterinary applications for bovine, porcine, equine, and avian fertility assessment.

Meridian Bioscience is a leading manufacturer of molecular and immunological reagents for diagnostic applications, operating through two primary divisions: Life Science and Diagnostics. The Life Science division develops reagents, antibodies, and molecular biology products for research and discovery applications, including lyophilized DNA fragmentation kits and NGS (next-generation sequencing) portfolio items. The Diagnostics division manufactures best-in-class diagnostic platforms, assays, and tests with comprehensive customer education and technical support. The company serves clinical laboratories, research institutions, and healthcare providers globally with products spanning from discovery phase through clinical diagnosis. Meridian maintains ISO and regulatory compliance across its product lines and operates manufacturing and service facilities in the United States (Cincinnati headquarters and Memphis Life Science facility), Canada, China, Germany, Israel, Italy, and the United Kingdom. The company provides technical support through dedicated customer service teams for both divisions, including diagnostic technical services and product support centers. Meridian's operations encompass reagent manufacturing, diagnostic platform development, and comprehensive laboratory support services.

Cleveland Diagnostics, Inc. is a molecular diagnostics company specializing in blood-based cancer biomarker testing. The company develops and commercializes the IsoClear™ platform, a proprietary protein structural analysis technology that measures biomarker characteristics to identify cancer cell origin and distinguish aggressive disease from benign conditions. Their flagship product, IsoPSA, is a blood test for prostate cancer risk stratification that demonstrates superior specificity (2–3 times higher) compared to traditional PSA testing and reduces unnecessary prostate biopsies by up to 55% according to published clinical data. The IsoClear platform is designed to enable rapid development of a portfolio of affordable, accessible blood tests across multiple cancer types. Cleveland Diagnostics operates laboratory testing services from their Cleveland, Ohio headquarters and serves urology and oncology practices, hospital systems, and health systems nationwide. The company focuses on early cancer detection and risk assessment for high-grade disease, offering clinicians improved diagnostic clarity to guide treatment decisions and reduce patient harm from overdiagnosis and unnecessary interventions.